logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

La Jolla Pharmaceutical Company


USPTO Granted Patents = 42


Trademarks = 3

Forward Citations = 513

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal David S Jones (15 out of 24 patents)

silverMedal Stephen M Coutts (11 out of 14 patents)

bronzeMedal Douglas Alan Livingston (10 out of 19 patents)

4.  Lin Yu (10 out of 12 patents)

5.  James Rolke (9 out of 12 patents)

6.  Mark Staples (9 out of 14 patents)

7.  Paul A Barstad (5 out of 6 patents)

8.  Michael J Conrad (5 out of 18 patents)

9.  David Matthew Marquis (4 out of 27 patents)

10.  Edward Jess Victoria (4 out of 4 patents)

11.  G Michael Iverson (3 out of 5 patents)

12.  Gilbert M Iverson (3 out of 3 patents)

13.  David H Katz (3 out of 24 patents)

14.  John P Hachmann (3 out of 4 patents)

15.  Matthew D Linnik (2 out of 2 patents)


Core Competencies:
Glycolipids
Endoglycoceramidases
Renal Failure Treatment
Modified Pectins
Valency Platform Molecules
Humoral Anergy
Oligonucleotide Synthesis
Cyclic Polypeptides
Therapeutic Polypeptides
D-GL Conjugate Therapy
Immunoreactive Peptides
Biologically Stable Polymers

42 patents:

1. 10555959 - Glycolipids as treatment for disease (2020-02-11),
2. 10294504 - Mutant endoglycoceramidases with enhanced synthetic activity (2019-05-21),
3. 9457059 - Compositions and methods for treating renal failure (2016-10-04),
4. 9181354 - Modified pectins, compositions and methods related thereto (2015-11-10),
5. 8877263 - Modified pectins, compositions and methods related thereto (2014-11-04),
6. 8722111 - Modified pectins, compositions and methods related thereto (2014-05-13),
7. 8722107 - Modified pectins, compositions and methods related thereto (2014-05-13),
8. 8658224 - Modified pectins, compositions and methods related thereto (2014-02-25),
9. 8420133 - Modified pectins, compositions and methods related thereto (2013-04-16),
10. 8409635 - Modified pectins, compositions and methods related thereto (2013-04-02),
11. 8187642 - Modified pectins, compositions and methods related thereto (2012-05-29),
12. 8128966 - Modified pectins, compositions and methods related thereto (2012-03-06),
13. 7351855 - Chemically defined non-polymeric valency platform molecules and conjugates thereof (2008-04-01),
14. 7208156 - Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule (2007-04-24),
15. 7163683 - Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule (2007-01-16),
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients suffering from life-threatening diseases. With a focus on discovering novel solutions, the company aims to address unmet medical needs and improve patient outcomes. La Jolla Pharmaceutical Company is committed to conducting clinical trials and advancing the treatment options available in critical care settings.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
42 Patents

#138 in San Diego, CA

#1,883 in California

#7,983 in US

#15,862 in the World

...
San Diego, CA, United States of America

La Jolla Pharmaceutical Company

Forward Citations = 513

23 inventors:

goldMedal David S Jones (15 out of 24 patents)

silverMedal Stephen M Coutts (11 out of 14 patents)

bronzeMedal Douglas Alan Livingston (10 out of 19 patents)

4.  Lin Yu (10 out of 12 patents)

5.  James Rolke (9 out of 12 patents)

Please report any incorrect information to support@idiyas.com
Loading…